Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

Clinical trial NCT07527520 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07527520
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Moderately Hypofractionated Radiotherapy Serplulimab pMMR/MSS

Start date: 2026-06-01
Primary completion: 2028-07-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.